Egalet Shares Outstanding 2012-2018 | EGLT

Egalet shares outstanding history from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Egalet shares outstanding for the quarter ending June 30, 2018 were 0.053B, a 108.68% increase year-over-year.
  • Egalet 2017 shares outstanding were 0.034B, a 37.69% increase from 2016.
  • Egalet 2016 shares outstanding were 0.025B, a 24.2% increase from 2015.
  • Egalet 2015 shares outstanding were 0.02B, a 35.59% increase from 2014.
Egalet Annual Shares Outstanding
(Millions of Shares)
2017 34
2016 25
2015 20
2014 15
2013 1
2012 1
2011 1
2006 0
2005 0
Egalet Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 53
Q1 2018 47
Q4 2017 34
Q3 2017 41
Q2 2017 26
Q1 2017 25
Q4 2016 25
Q3 2016 25
Q2 2016 24
Q1 2016 24
Q4 2015 20
Q3 2015 22
Q2 2015 17
Q1 2015 16
Q4 2014 15
Q3 2014 16
Q2 2014 16
Q1 2014 10
Q4 2013 1
Q3 2013 1
Q2 2013 1
Q1 2013 1
Q4 2012 0
Q3 2012 0
Q2 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.006B $0.026B
Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in the developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications. Its principal product candidate consist of Egalet-001, is an abuse-deterrent, extended-release, oral morphine formulation in development for the treatment of moderate to severe pain, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation in development for the treatment of moderate to severe pain and Egalet-003 which are in pre-clinical trials. Egalet Corporation is based in City of Westminster, United Kingdom.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.347B 11.30
Zoetis (ZTS) United States $44.236B 32.10
Tilray (TLRY) United States $14.752B 0.00
Grifols (GRFS) Spain $13.499B 16.48
Neurocrine Biosciences (NBIX) United States $10.340B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.537B 14.03
Nektar Therapeutics (NKTR) United States $8.705B 10.18
Ionis Pharmaceuticals (IONS) United States $6.519B 0.00
Catalent (CTLT) United States $6.226B 26.80
Sage Therapeutics (SAGE) United States $5.809B 0.00
United Therapeutics (UTHR) United States $5.534B 7.11
Impax Laboratories (AMRX) United States $5.513B 29.32
Loxo Oncology (LOXO) United States $5.170B 0.00
FibroGen (FGEN) United States $4.514B 0.00
Endo (ENDP) Ireland $4.098B 5.88
Taro Pharmaceutical Industries (TARO) Israel $3.749B 14.52
Madrigal Pharmaceuticals (MDGL) United States $3.147B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.697B 0.00
Aerie Pharmaceuticals (AERI) United States $2.676B 0.00
USANA Health Sciences (USNA) United States $2.615B 23.03
TESARO (TSRO) United States $2.383B 0.00
Heron Therapeutics (HRTX) United States $2.369B 0.00
Xencor (XNCR) United States $2.043B 0.00
PTC Therapeutics (PTCT) United States $1.996B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.926B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.677B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.555B 19.02
Spectrum Pharmaceuticals (SPPI) United States $1.534B 0.00
Corcept Therapeutics (CORT) United States $1.525B 23.46
Portola Pharmaceuticals (PTLA) United States $1.519B 0.00
Zogenix (ZGNX) United States $1.502B 0.00
TherapeuticsMD (TXMD) United States $1.382B 0.00
Esperion Therapeutics (ESPR) United States $1.338B 0.00
Tricida (TCDA) United States $1.281B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.221B 0.00
ImmunoGen (IMGN) United States $1.194B 0.00
Endocyte (ECYT) United States $1.122B 0.00
Radius Health (RDUS) United States $0.915B 0.00
Karyopharm Therapeutics (KPTI) United States $0.794B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.789B 0.00
Flexion Therapeutics (FLXN) United States $0.741B 0.00
GlycoMimetics (GLYC) United States $0.604B 0.00
Dova Pharmaceuticals (DOVA) United States $0.597B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
ChemoCentryx (CCXI) United States $0.579B 33.82
Crinetics Pharmaceuticals (CRNX) United States $0.563B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.531B 0.00
Dermira (DERM) United States $0.522B 0.00
Akebia Therapeutics (AKBA) United States $0.521B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.508B 0.00
ArQule (ARQL) United States $0.507B 0.00
OptiNose (OPTN) United States $0.455B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 30.70
Forty Seven (FTSV) United States $0.446B 0.00
Odonate Therapeutics (ODT) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.421B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.416B 0.00
Minerva Neurosciences (NERV) United States $0.414B 0.00
Xeris Pharmaceuticals (XERS) United States $0.410B 0.00
Aclaris Therapeutics (ACRS) United States $0.386B 0.00
Aquestive Therapeutics (AQST) United States $0.386B 0.00
Zafgen (ZFGN) United States $0.385B 0.00
Mast Therapeutics (SVRA) United States $0.377B 0.00
Depomed (ASRT) United States $0.374B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.367B 0.00
Concert Pharmaceuticals (CNCE) United States $0.364B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.358B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.356B 0.00
ElectroCore (ECOR) United States $0.355B 0.00
KalVista Pharmaceuticals (KALV) United States $0.333B 0.00
Majesco Entertainment (PTE) United States $0.330B 0.00
Translate Bio (TBIO) United States $0.322B 0.00
CASI Pharmaceuticals (CASI) United States $0.295B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.287B 0.00
MEI Pharma (MEIP) United States $0.285B 0.00
Aldeyra Therapeutics (ALDX) United States $0.271B 0.00
Tyme Technologies (TYME) United States $0.266B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.262B 0.00
Aratana Therapeutics (PETX) United States $0.257B 0.00
Ocular Therapeutix (OCUL) United States $0.249B 0.00
Ardelyx (ARDX) United States $0.247B 0.00
Opexa Therapeutics (ACER) United States $0.246B 0.00
IMV INC (IMV) Canada $0.241B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.241B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.238B 0.00
Neon Therapeutics (NTGN) United States $0.229B 0.00
Melinta Therapeutics (MLNT) United States $0.216B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Calithera Biosciences (CALA) United States $0.211B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Jounce Therapeutics (JNCE) United States $0.199B 0.00
Molecular Templates (MTEM) United States $0.191B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.190B 0.00
Achaogen (AKAO) United States $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.185B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.169B 0.00
India Globalization Capital (IGC) United States $0.165B 0.00
MediWound (MDWD) Israel $0.164B 0.00
ContraFect (CFRX) United States $0.164B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.163B 0.00
Lannett Co Inc (LCI) United States $0.162B 1.34
Avadel Pharmaceuticals (AVDL) Ireland $0.161B 0.00
Nature's Sunshine Products (NATR) United States $0.157B 0.00
DURECT (DRRX) United States $0.155B 0.00
BioLineRx (BLRX) Israel $0.151B 0.00
Adherex Technologies (FENC) United States $0.149B 0.00
Recro Pharma (REPH) United States $0.149B 0.00
Infinity Pharmaceuticals (INFI) United States $0.147B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.137B 0.00
Champions Oncology (CSBR) United States $0.133B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.130B 0.00
Cardiome Pharma (CORV) Canada $0.125B 0.00
Neos Therapeutics (NEOS) United States $0.120B 0.00
CTI BioPharma (CTIC) United States $0.115B 0.00
Rafael Holdings (RFL) United States $0.110B 0.00
ENTASIS THERAPT (ETTX) United States $0.109B 0.00
Forward Pharma (FWP) Denmark $0.094B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.083B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.079B 0.00
Immune Design (IMDZ) United States $0.079B 0.00
Natural Alternatives (NAII) United States $0.072B 8.10
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Novan (NOVN) United States $0.067B 0.00
Genocea Biosciences (GNCA) United States $0.066B 0.00
Trillium Therapeutics (TRIL) Canada $0.057B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 40.48
Ampio Pharmaceuticals (AMPE) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.44
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Capnia (SLNO) United States $0.041B 0.00
KemPharm (KMPH) United States $0.041B 0.00
Heat Biologics (HTBX) United States $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.039B 0.00
Onconova Therapeutics (ONTX) United States $0.036B 0.00
Avenue Therapeutics (ATXI) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Biomerica (BMRA) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.30
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.023B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
Shineco (TYHT) China $0.019B 1.92
Cyanotech (CYAN) United States $0.019B 0.00
Aradigm (ARDM) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Midatech Pharma (MTP) United Kingdom $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
PharmAthene (ALT) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00